Aine Miller serves as Executive at Theravance Biopharma, Inc., where they oversee executive responsibilities. Since joining the company, Aine Miller has executed 7 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Feb 20, 2026 involved selling 16,851 shares valued at $331.3K.
Aine Miller currently holds 184,161 shares of Theravance Biopharma, Inc. (TBPH), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Aine Miller has been a net neutral trader of TBPH stock. They have purchased $0 and sold $0 worth of shares.
Aine Miller's most recent insider trade was on Feb 20, 2026, when they sold 16,851 shares at $19.66 per share.
Get notified when new Form 4 filings are submitted
| $17.90 |
| Discretionary |
| Aug 20, 2025 | TBPH | $93.6K | Payment | 6,989 | $13.39 | Discretionary |
| Aug 20, 2024 | TBPH | $42.8K | Payment | 5,201 | $8.22 | Discretionary |
| May 20, 2024 | TBPH | $47.3K | Payment | 5,201 | $9.10 | Discretionary |
| Apr 2, 2024 | TBPH | $0 | Award | 37,500 | $N/A | Discretionary |
| Feb 20, 2024 | TBPH | $105.1K | Payment | 11,782 | $8.92 | Discretionary |